Skip to content
Search

Latest Stories

UK could avoid 20,000 cancer deaths a year by 2040 with an ambitious plan, says charity

UK Cancer Crisis
UK could avoid 20,000 cancer deaths a year by 2040 with an ambitious plan

Cancer Research UK has estimated that half a million people will be diagnosed with the disease every year by 2040  

The UK is lagging behind comparable countries when it comes to cancer survival, Cancer Research UK (CRUK) has said, calling on all political parties to make cancer a top priority in their party manifestos.


While cancer survival rates in the UK have doubled over the last 50 years, the charity warned that the hard-won progress is at risk of stalling, with NHS cancer services in “crisis” and around half a million cancer cases a year projected by 2040.

The charity has published an ambitious cancer plan which, if adopted by the next UK government, could dramatically improve cancer outcomes and prevent 20,000 cancer deaths a year by 2040.

Called “Longer Better Lives: A Manifesto for Cancer Research and Care”, the plan has been developed with the insights of cancer patients and experts from across health, life sciences, government and academic sectors, it said.

“Avoiding thousands of cancer deaths is possible, but it will take leadership, political will, investment and reform,” said Michelle Mitchell, chief executive of Cancer Research UK, and urged all political leaders to unite behind this “vital mission.”

The charity also stressed the need for an urgent action to address “the more than £1 billion funding gap for research into cancer” over the next decade, which will put hard-won medical advances at risk if not dealt with.

Additionally, it has recommended for establishment of a nation-wide movement on cancer, spearheaded by a National Cancer Council, to tackle these complex challenges.

The five missions for the next UK Government

In the manifesto, CRUK has outlined five missions for the next government to follow to dramatically improve cancer outcomes.

These include – rebuilding the UK’s global position in biomedical research, strengthening measures to achieve a Smokefree England by 2030, reducing late-stage diagnosis and inequalities in early diagnosis in England, bringing vital tests and treatment to patients more quickly, and building a national movement to beat cancer together.

Cancer Research UK is also calling on the government to set out a 10-year cancer-specific workforce plan to address the chronic staff shortages in cancer services, and to eliminate the £10.2 billion NHS maintenance deficit by 2030.

Advances in the prevention, diagnosis and treatment of cancer have helped saved more than one million lives in the UK since the late 1980s, according to the charity, which highlighted the importance of increasing investment in cancer research.

How community pharmacists can help in cancer management

As community pharmacists are easily accessible, they are usually the first point of contact with the public. Today a pharmacist’s role is not just restricted to dispensing medications, they are now running screening programmes and participating in more clinical interventions. With the launch of the NHS Pharmacy First service next year, pharmacists in the UK will also start prescribing medications for seven common conditions.

With support from the NHS, community pharmacists can play an essential part in risk assessment, screening, early diagnosis and even in the management of cancer.

Explaining the potential role of pharmacists in cancer management, Royal Pharmaceutical Society (RPS) President Professor, Claire Anderson told Business Pharmacy: “Between 30-50 per cent of cancers are preventable, with smoking and obesity being the leading causes, and community pharmacists are well-positioned to address these issues by offering lifestyle advice and support."

“Pharmacists play a crucial role in smoking cessation services and contribute to public health campaigns focused on cancer awareness. Additionally, community pharmacists provide basic health assessments, support lifestyle changes, and raise awareness about cancer symptoms.

“There are several successful pilot programs and frameworks across the three nations that demonstrate their effectiveness in risk estimation and early cancer detection, emphasising the vital role community pharmacists can play in cancer prevention. These accessible health services are also located in areas of higher deprivation, which put them at the front line of improving health inequalities," Claire added.

RPS, in its previous report entitled ‘Utilising community pharmacists to support people with cancer’, had highlighted the role of pharmacies in the fight against cancer, especially during early diagnosis.

 

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less